Translational vehicles for neuroprotection.
This review will analyse particular criteria in the analysis of stroke diagnosis and treatment, which are pivotal for the successful translation of experimental data from the laboratory to humans.
Papadakis
M
M
Acute Stroke Programme, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Buchan
A M
AM
D000818:Animals; D001557:Benzenesulfonates / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000628:therapy*; D004195:Disease Models, Animal; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D014176:Protein Biosynthesis; D020521:Stroke / Q000188:drug therapy / Q000628:therapy*; D015912:Thrombolytic Therapy
D001557:Benzenesulfonates; D018696:Neuroprotective Agents; C120851:disufenton sodium